GSK

#News for #investors and #media: Today, we are announcing that one of our liver medicines has been approved by the US Food and Drug Administration (FDA). Find out more: gsk.to/4sTSzv0

#News for #Investors and #Media: Today, we are announcing that one of our vaccines has been approved for an expanded population by the US Food and Drug Administration (FDA). Learn more: gsk.to/47Kyn6H

Hi Shantanu, thanks for your message. We've received several reports about a recruitment scam circulating from hiring@careers-gsk.com for a Data Analyst role. We're actively investigating this, and we appreciate you bringing it to our attention. If you've received one of these emails, please help us by forwarding all relevant details and materials to askus@gsk.com. A reminder that GSK will never ask for payment at any stage of our recruitment process. Thank you for your support.

@GSKUS Is hiring@careers-gsk.com a genuine email address used by GSK for recruitment in India?

We‘ve topped the Access to Medicine Index's 2026 Antimicrobial Resistance Benchmark, reflecting our continuous focus on delivering innovative antibiotic medicines and vaccines for patients with significant unmet medical need. Check out our #AMR podcast: gsk.to/4rYwjQD

Thanks for bringing this to our attention. At GSK, we have clear policies and a strong commitment to respectful conduct and compliance with local laws and regulations, both inside and outside of work. We are taking this matter seriously and are reviewing it in line with our internal processes. Thank you for your time.

@ksa_90x هذا حساب الشركة اللي يشتغل فيها ارسلو لها ان هالشخص عنصري بغيض ويدعم الحروب وراح يطيرونه @GSK

مصري مقيم في الرياض اسمه وليد محمد ابراهيم ويعمل مدير مبيعات في شركة GSK السعوديه عبر منشور يسيء للوطن،

As #SLEuro wraps up, we reflect on 15 years of pioneering progress in lupus research and innovation at GSK. We continue to innovate to target the underlying drivers of disease and remain dedicated to helping the lives of millions of patients living with lupus worldwide.

#Investors and #Media Please read our cautionary statement regarding forward-looking statements and the definitions and reconciliations for non-IFRS measures in our 2025 Annual Report. CER% represents constant exchange rates. AER% represents actual exchange rates. $GSK For investors: gsk.com/en-gb/investor…

Our latest Annual Report and Responsible Business Report show our progress in creating value for patients and shareholders. Take a look at the highlights ⤵️ 🔗 Investors and media can read more: gsk.to/4ubX9pQ

#News for #investors and #media: Today we announced the completion of our acquisition of RAPT Therapeutics, adding to our growing Respiratory, Immunology & Inflammation (RI&I) pipeline. Find out more: gsk.to/4b3MN2O

@4xuHkAOxS29TACZ Hi Hussein, thanks for getting in touch. We'd love to help but industry regulations mean we're not able to discuss our medicines with you here. Your doctor or healthcare professional will be best placed to support. We hope this helps.

@GSK Will you be distributing hepatitis B treatment in 2026 for hepatitis B disease?@GSK

#News for #investors and #media: Today we are announcing that our potential first-in-class treatment for chronic hepatitis B has been accepted for regulatory review in Japan. Learn more: gsk.to/3MGEOk5

@kanav1984 Hi Kanav, thanks for your interest in working with us. Please visit gsk.com/en-gb/careers/ to find all our available job opportunities. Best of luck!

Hi @GSK I HAVE BEEN A highly appreciated CORPORATE ADVISOR IN PREVIOUS COMPANY FOR BUSINESS GROWTH. By the way, I am Software Expert. I am based in India & looking for remote role ONLY. Have a great day, Kanav Aggarwal +91 890 419 4554 kanav1984@gmail.com

@valk_carol54842 Hi. Thank you for reaching out to us. We're sorry to hear that our campaign caused any offense. We value your feedback and have shared your comments with the relevant team. Thank you.

@GSK wat een infantiele reclame met je ‘aan m’n fiets hangen’ Lekker popi Mijn oma heeft hier lange tijd heel veel pijn door geleden En dan dat suffe muziekje eronder

@andyangyi Hello. Thanks for reaching out. We'd love to help but industry regulations mean we're not able to discuss our medicines with you. Your doctor or healthcare professional will be best placed to support. We hope this helps.

@GSK @ViiVHC I’ve been talking the davoto for 8 years, I know the patent will be expired this year, what will happen? Do we have new cutting edge medicine ?

News for #Investors and #Media: Today at #CROI2026, our specialist HIV company @ViiVHC, presented new insights on our investigational long-acting therapies. 🔗 Find out more on our website: gsk.to/4rDvSew

@JudyHeinken Hi Judy. Thanks for reaching out. We'd love to help but industry regulations mean we're not able to discuss our medicines with you. Your doctor or healthcare professional will be best placed to support. We hope this helps.

@GSK When will Trelegy be given Most Favored Nation status?

#News for #investors and #media: We’ve announced an agreement to acquire 35Pharma. Find out more: gsk.to/4kS3iUd

@4xuHkAOxS29TACZ Thanks for your interest. You can learn more about our clinical trials process and ongoing studies via our website: gsk.com/en-gb/innovati…

@GSK @mohitagarwal_50 @TOIMumbai @Haleon_health Good morning. When will the treatment for hepatitis B be available by the end of the year?

Not sure, but medicine purchased in #Mumbai appeared to have limited effectiveness. Tagging @GSK to verify authenticity (bought from MedPlus). Stopping fake may be difficult for the #government, since it could also lead to joblessness in criminal world. @CMOMaharashtra @grok

@AdityaG42278765 Hello Aditya. Thanks for your interest in working with us! You can find out more about our internships and placements here: gsk.com/en-gb/careers/…. Good luck!

@GSK A third-year B.Pharm student seeks a 1-month training placement to learn CGMP, quality control, and large-scale formulation. Includes resume and transcripts; eager to contribute and available for discussion.